Detalhe da pesquisa
1.
A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies.
Cancer
; 125(10): 1629-1636, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30645764
2.
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial.
JAMA Netw Open
; 3(2): e1921290, 2020 02 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32058557
3.
Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma.
Cancer Discov
; 8(1): 37-48, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978556
4.
Clinical Activity of Olaparib in Urothelial Bladder Cancer With DNA Damage Response Gene Mutations.
JCO Precis Oncol
; 2: 1-7, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35135165